^
Association details:
| Biomarker: | TTF1 expression + PD-L1 overexpression |
|---|---|
| Cancer: | Lung Adenocarcinoma |
| Drug Class: | Immunotherapy |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Clinical impact of TTF-1 for Combined Chemoimmunotherapy Efficacy in Lung Adenocarcinoma: A Multicenter Prospective Study
Published date:
08/08/2023
Excerpt:
Multivariate analyses revealed that TTF-1 positivity and PD-L1 TPS ≥ 50% were independent predictive factors for prolonged PFS (p = 0.01, p = 0.01, respectively).
